header
Medical Project Southern Sudan
Dr Jill Seaman returns to Duar
Dr Jill Seaman returns to Duar

Sudan, in Sub-Saharan Africa, has been plagued by armed conflict. Civil war between the black Africans of South Sudan and the Islamic regime in North Sudan re-ignited in 1983. The Nuer people, semi-nomadic cattle herders, became a casualty of this civil war. Disease and famine are commonplace. Most of Nuerland has essentially no infrastructure - no markets, no cash economy, no transportation save your own feet, and especially no established educational or health care services.

Jill Seaman, MD, and Sjoukje de Wit, RN, have worked with the Nuer since 1989 and 1993 respectively. They helped establish TB treatment in the West Upper Nile region of Sudan under the auspices of the non-government organization (NGO) Doctors Without Borders (Medecins Sans Frontiers, or MSF). MSF closed this program when security risks became overwhelming. The Nuer, however, could not escape. TB became one of their most lethal infectious diseases. They begged medical workers to return. Since no NGOs were willing to start treatment in such an unstable war zone, Ms. de Wit and Dr. Seaman with financial and moral support from their friends re-entered the area in July 2000.

Sudan is located in Northeastern Africa. (Lanken is half way between Malakal and Bor and to the east, and Keew is half way between Malakal and Bor and to the west.) It is Africa's largest country - about one quarter the size of the United States. Seasons are defined by dramatic differences in rainfall that occur between the wet and dry seasons.

In the first year they treated 291 patients in the village of Lanken. This program was so successful that MSF was eager to take it over in 2001, leaving Seaman and de Wit able to move on to Keew. In 2001-2002, they treated 193 patients with 96% completing therapy! In Lanken, MSF also completed a successful TB project. MSF used the South Sudan TB Project’s data, with extensive input from Dr. Seaman, to report that TB treatment in South Sudan is not only possible, but highly effective. While the possibility of treating this lethal disease brings hope to those isolated in Sudan, sociopolitical events darken the picture. Since the discovery of oil under the traditional lands of the nomadic Dinka and Nuer tribes, war has only escalated. The government of north Sudan, which wants land open for oil extraction, keeps civilians on the run.

The 50,000 inhabitants of our catchment area had never had TB treatment available before. Some walk for days, or carry those too weak to walk, to get to the treatment center. Local political leaders and health workers volunteer their time, effort, and good will to make this program successful.

Last year, the Nuer people around Keew signed a peace accord with the Dinka tribe, many of whom live nearby in the east (Atar), and the north (Ruweng). One fortuitous byproduct of their agreement was that Sjoukje and Jill could offer TB treatment in Keew to those they identified during a brief foray to the north. The new Dinka patients were taken in by Nuer hosts for their four months of inpatient treatment—a small step toward peace between former enemies, and outreach to a wider population.

TB continues to be one of the top infectious killers in the world today. In Sub-Saharan Africa, approximately 300 per 100,000 are sickened annually by this disease. Good incidence data for a semi-nomadic pastoral tribe in a war zone is difficult to obtain, but we have several indicators of concern. One study shows a prevalence of more than 600 per 100,000 population with active TB, in an area without access to treatment. Another data set, with very small numbers, shows a phenomenal infection rate, with 65% of the 4 -10 year old children having a positive skin test for TB. Probably the most reliable indicator is the persistence with which the local people ask for TB treatment.

While 30% of our patients suffer from spinal TB (a rather uncommon variant of the disease that often leaves its victims unable to walk), there are elements of hope. We have not seen any HIV infection, which makes the TB situation easier to address. This year more than 96% of the patients completed their four months of daily therapy, with staff watching as each pill was swallowed.

Though the scope of this proposal appears small, its impact extends much farther. Untreated TB is usually either debilitating or fatal. Every person with pulmonary TB is said to infect 10-14 people a year. Where famine occurs regularly, a disabled parent often means starvation for the whole family. Treating one patient may save many lives. TB treatment is as cost-effective as vaccination campaigns. Statistics aside, our goal is to bring hope to a desperate community.

 

Website by Jeff van den Bosch